Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Has announcements × Cisplatin × Clear all

Phase

Status

Sponsor Class

INDUSTRY 29 OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Ototoxicity 1 Liver Neoplasms 1 Hepatoblastoma 1

Interventions

toripalimab 1 sodium thiosulfate 1 naxitamab 1 Vincristine 1 Rituximab 1 Methotrexate 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Eflornithine 1 Drug Therapy 1 Doxorubicin 1 Daunorubicin 1 Cytarabine 1 Cyclophosphamide 1 Cisplatin 1 Abatacept 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00652132 2018-05-29

SIOPEL6

University of Birmingham

Phase 3 Completed

116 enrolled 1 FDA

Gastrointestinal

Ototoxicity, Liver Neoplasms, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡